nivolumab,ipilimumab,cabozantinib,sunitinib
bms,pfizer
['nivolumab', 'sunitinib', 'cabozantinib', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'check,mate,9er', 'nivo']
3-year follow-up on phase 3 checkmate 9er #kidneycancer trial shows combo of cabozantinib and nivolumab maintained clinically meaningful benefit in long-term survival over sunitinib. data presented at asco #gu23 's explains more. cc: 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090